MedTrace Logo

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

NCT02354378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2019-02-28

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in children has not been studied.

Conditions

  • Memory
  • Dexmedetomidine

Interventions

DRUG

Dexmedetomidine

OTHER

Memory Test

Sponsors & Collaborators

Principal Investigators

  • Keira Mason, MD · Boston Children's Hospital

Eligibility

Min Age
4 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354378 on ClinicalTrials.gov